M. Devonec

2.4k total citations
106 papers, 1.7k citations indexed

About

M. Devonec is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery. According to data from OpenAlex, M. Devonec has authored 106 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 45 papers in Urology and 38 papers in Surgery. Recurrent topics in M. Devonec's work include Prostate Cancer Diagnosis and Treatment (50 papers), Urinary Bladder and Prostate Research (38 papers) and Bladder and Urothelial Cancer Treatments (29 papers). M. Devonec is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (50 papers), Urinary Bladder and Prostate Research (38 papers) and Bladder and Urothelial Cancer Treatments (29 papers). M. Devonec collaborates with scholars based in France, United States and Belize. M. Devonec's co-authors include Paul B. Perrin, A. Ruffion, P. Paparel, Virginie Vlaeminck‐Guillem, Myriam Decaussin‐Petrucci, M. Fourmarier, O. Haillot, C. Chouvet, S Saez and C. Saussine and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and International Journal of Molecular Sciences.

In The Last Decade

M. Devonec

102 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Devonec France 23 831 739 541 387 278 106 1.7k
Alexandré Pelzer Austria 26 1.1k 1.3× 360 0.5× 316 0.6× 288 0.7× 344 1.2× 98 1.9k
Hans‐Helge Seifert Switzerland 24 772 0.9× 409 0.6× 354 0.7× 271 0.7× 751 2.7× 76 1.8k
Kevin M. Tomera United States 19 816 1.0× 428 0.6× 330 0.6× 237 0.6× 276 1.0× 36 1.5k
Koji Okihara Japan 24 1.3k 1.5× 310 0.4× 330 0.6× 329 0.9× 499 1.8× 132 2.0k
Fabien Saint France 30 1.4k 1.6× 606 0.8× 1.6k 3.0× 498 1.3× 517 1.9× 65 2.9k
Kenneth B. Cummings United States 28 952 1.1× 556 0.8× 1.1k 2.0× 377 1.0× 290 1.0× 88 2.3k
Levent Türkeri Türkiye 22 628 0.8× 689 0.9× 1.5k 2.7× 230 0.6× 335 1.2× 126 2.2k
N. Schmeller Germany 26 846 1.0× 237 0.3× 872 1.6× 227 0.6× 541 1.9× 92 2.0k
Wim P.J. Witjes Netherlands 29 1.4k 1.7× 1.2k 1.6× 982 1.8× 675 1.7× 236 0.8× 92 2.8k
Guilherme Godoy United States 29 1.5k 1.8× 422 0.6× 1.4k 2.6× 365 0.9× 551 2.0× 86 2.7k

Countries citing papers authored by M. Devonec

Since Specialization
Citations

This map shows the geographic impact of M. Devonec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Devonec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Devonec more than expected).

Fields of papers citing papers by M. Devonec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Devonec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Devonec. The network helps show where M. Devonec may publish in the future.

Co-authorship network of co-authors of M. Devonec

This figure shows the co-authorship network connecting the top 25 collaborators of M. Devonec. A scholar is included among the top collaborators of M. Devonec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Devonec. M. Devonec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devonec, M., et al.. (2020). A new temporary prostatic stent to replace the Foley catheter in men with acute or chronic urinary retention: First 84 cases. European Urology Open Science. 19. e998–e998. 1 indexed citations
2.
Vlaeminck‐Guillem, Virginie, et al.. (2015). Test urinaire PCA3 et diagnostic du cancer prostatique : étude à partir de 1015 patients. Progrès en Urologie. 25(16). 1160–1168. 6 indexed citations
3.
Bari, Berardino De, Olivier Rouvière, A. Ruffion, et al.. (2013). Does hormone therapy modify the position of the gold markers in the prostate during irradiation? A daily evaluation with kV-images. Cancer/Radiothérapie. 17(3). 215–220. 7 indexed citations
4.
Ruffion, A., M. Devonec, Myriam Decaussin‐Petrucci, et al.. (2013). PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy. International Journal of Molecular Sciences. 14(9). 17767–17780. 32 indexed citations
5.
Vlaeminck‐Guillem, Virginie, Karim Chikh, Myriam Decaussin‐Petrucci, et al.. (2011). Value of PCA3 urinary test for prostate biopsy decision: the Lyon-Sud University Hospital experience. Annales de biologie clinique. 69(1). 31–39. 8 indexed citations
6.
Delongchamps, Nicolas Barry, G. Robert, A. Descazeaud, et al.. (2011). Traitement chirurgical de l’hyperplasie bénigne de la prostate par thermothérapie et autres techniques émergentes : revue de littérature du CTMH de l’AFU. Progrès en Urologie. 22(2). 87–92. 10 indexed citations
7.
Robert, G., A. Descazeaud, Nicolas Barry Delongchamps, et al.. (2010). Transurethral plasma vaporization of the prostate: 3‐month functional outcome and complications. British Journal of Urology. 110(4). 555–560. 17 indexed citations
8.
Vlaeminck‐Guillem, Virginie, A. Ruffion, Jean André, M. Devonec, & P. Paparel. (2009). Urinary Prostate Cancer 3 Test: Toward the Age of Reason?. Urology. 75(2). 447–453. 65 indexed citations
9.
10.
11.
Descazeaud, A., G. Robert, C. Ballereau, et al.. (2008). Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. British Journal of Urology. 103(9). 1162–1165. 28 indexed citations
12.
Timsit, Marc‐Olivier, P. Paparel, M. Devonec, et al.. (2006). [REMEEX: A possible treatment option in selected cases of sphincter incompetence].. PubMed. 16(2). 184–91. 23 indexed citations
13.
Ruffion, A., Anne‐Marie Manel, W. Massoud, et al.. (2005). Preservation of prostate during radical cystectomy: Evaluation of prevalence of prostate cancer associated with bladder cancer. Urology. 65(4). 703–707. 34 indexed citations
14.
Manel, Anne‐Marie, et al.. (2003). High prevalence of prostate cancer associated with bladder cancer. European Urology Supplements. 2(1). 87–87. 2 indexed citations
15.
Pfister, Christian, Denis Chautard, M. Devonec, et al.. (2003). Immunocyt Test Improves the Diagnostic Accuracy of Urinary Cytology: Results of a French Multicenter Study. The Journal of Urology. 169(3). 921–924. 102 indexed citations
16.
Devonec, M. & Christer Dahlstrand. (1998). Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate. World Journal of Urology. 16(2). 120–123. 20 indexed citations
17.
Devonec, M., Kevin M. Tomera, & Paul B. Perrin. (1993). Review: Transurethral Microwave Thermotherapy in Benign Prostatic Hyperplasia. Journal of Endourology. 7(3). 255–259. 36 indexed citations
18.
Perrin, Paul B., et al.. (1991). [Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate].. PubMed. 20(28). 1313–9.
19.
Devonec, M., et al.. (1987). Evaluation of Bladder Cancer with a Miniature High Frequency Transurethral Ultrasonography Probe. British Journal of Urology. 59(6). 550–553. 12 indexed citations
20.
Devonec, M.. (1986). Place actuelle et future de la cytométrie en flux en cancérologie urologique.. Annales d Urologie. 20(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandré Pelzer Breakdown of academic impact, for papers by Hans‐Helge Seifert Breakdown of academic impact, for papers by Kevin M. Tomera Breakdown of academic impact, for papers by Koji Okihara Breakdown of academic impact, for papers by Fabien Saint Breakdown of academic impact, for papers by Kenneth B. Cummings Breakdown of academic impact, for papers by Levent Türkeri Breakdown of academic impact, for papers by N. Schmeller Breakdown of academic impact, for papers by Wim P.J. Witjes Breakdown of academic impact, for papers by Guilherme Godoy
Rankless by CCL
2026